Southern Company grabbed an eleven dollar hike from Barclays today. Nicholas Campanella lifted his target to $99 from $88 maintaining hold. The utility climbed despite broader defensive rotation as Iran war uncertainty persisted.
VRTX Vertex Pharmaceuticals rose on Morgan Stanley confidence. Terence Flynn boosted his target to $612 from $596 keeping buy. The biotech held strong analyst support with just one sell rating among 31 covering firms.
REGN Regeneron jumped to $796 from $769 at Morgan Stanley. Matthew Harrison maintained hold showing measured optimism on the $91B drugmaker.
Energy names absorbed mixed signals. FANG Diamondback Energy climbed to $245 from $240 at UBS as crude volatility continued. Josh Silverstein kept buy as oil held near $100.
Cruise operators faced downgrades. RCL Royal Caribbean dropped to $351 from $361 at Barclays despite maintaining buy. NCLH Norwegian fell to $21 from $22 on hold as travel demand uncertainty mounted.
MSFT Microsoft consensus target slipped to $585 from $587 showing minimal erosion. AVGO Broadcom consensus rose to $473 from $472 reflecting chip sector resilience.
Energy and healthcare dominated positive moves while travel absorbed fresh skepticism.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
